• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What are the clinical settings and outcomes of lean NAFLD?

作者信息

Ren Tian-Yi, Fan Jian-Gao

机构信息

Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China.

出版信息

Nat Rev Gastroenterol Hepatol. 2021 May;18(5):289-290. doi: 10.1038/s41575-021-00433-5.

DOI:10.1038/s41575-021-00433-5
PMID:33649583
Abstract
摘要

相似文献

1
What are the clinical settings and outcomes of lean NAFLD?非酒精性脂肪性肝病（NAFLD）的临床情况及转归如何？
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):289-290. doi: 10.1038/s41575-021-00433-5.
2
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
3
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.非酒精性脂肪性肝病在瘦人群体中的：预后、结局和管理。
World J Gastroenterol. 2020 Nov 14;26(42):6514-6528. doi: 10.3748/wjg.v26.i42.6514.
4
Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.脂肪肝指数和代谢因素在体检瘦人群体中非酒精性脂肪肝预测中的作用。
Clin Transl Gastroenterol. 2019 May 22;10(5):1-8. doi: 10.14309/ctg.0000000000000042.
5
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.系统评价与荟萃分析：非酒精性脂肪性肝病的危险因素表明，瘦型和肥胖型患者存在共同的代谢和心血管特征改变。
Aliment Pharmacol Ther. 2017 Jul;46(2):85-95. doi: 10.1111/apt.14112. Epub 2017 May 2.
6
Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.中等收入国家非酒精性脂肪性肝病瘦患者的评估；患病率及其与代谢紊乱的关联：一项横断面研究。
Arch Iran Med. 2017 Apr;20(4):211-217.
7
Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease.瘦型与非瘦型非酒精性脂肪性肝病的临床和代谢特征比较。
Indian J Gastroenterol. 2021 Aug;40(4):380-388. doi: 10.1007/s12664-021-01184-6. Epub 2021 Jul 2.
8
Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病瘦型中国成年人的患病率、临床特征、危险因素和指标。
World J Gastroenterol. 2020 Apr 21;26(15):1792-1804. doi: 10.3748/wjg.v26.i15.1792.
9
Non-alcoholic fatty liver disease: A real threat in Pakistan.非酒精性脂肪性肝病：巴基斯坦面临的现实威胁。
J Pak Med Assoc. 2020 Dec;70(12(B)):2437-2440. doi: 10.5455/JPMA.95891.
10
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征：高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.

引用本文的文献

1
Nonobese NAFLD subjects demonstrate lower risk of metabolic syndrome than obese non-NAFLD subjects: A multicenter cross-sectional study.非肥胖型非酒精性脂肪性肝病（NAFLD）患者比肥胖型非NAFLD患者表现出更低的代谢综合征风险：一项多中心横断面研究。
Medicine (Baltimore). 2025 Aug 29;104(35):e44187. doi: 10.1097/MD.0000000000044187.
2
Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals.血清白蛋白与肌酐比值和非酒精性脂肪性肝病之间的关联：一项针对非肥胖中国人群的纵向队列研究。
BMC Gastroenterol. 2025 Aug 27;25(1):620. doi: 10.1186/s12876-025-04201-6.
3

本文引用的文献

1
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?非酒精性脂肪性肝病的白种瘦体型受试者与非瘦体型受试者具有相似的长期预后：是否需要重新评估 BMI 驱动方法？
Gut. 2022 Feb;71(2):382-390. doi: 10.1136/gutjnl-2020-322564. Epub 2021 Feb 4.
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena.
非酒精性脂肪性肝病的发展：一种多因素致病现象。
Liver Res. 2022 May 19;6(2):72-83. doi: 10.1016/j.livres.2022.05.002. eCollection 2022 Jun.
4
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).《代谢功能障碍相关脂肪性肝病防治指南（2024年版）》
J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4.
5
Pesticides impacts on human health and the environment with their mechanisms of action and possible countermeasures.农药对人类健康和环境的影响及其作用机制与可能的应对措施。
Heliyon. 2024 Apr 4;10(7):e29128. doi: 10.1016/j.heliyon.2024.e29128. eCollection 2024 Apr 15.
6
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.炎症性肠病是瘦人代谢功能障碍相关脂肪性肝病的独立危险因素。
Inflamm Bowel Dis. 2024 Aug 1;30(8):1274-1283. doi: 10.1093/ibd/izad175.
7
Long working hours and increased risks of lean non-alcoholic fatty liver disease among Korean men and women.韩国男性和女性中，长时间工作与非酒精性脂肪肝消瘦型患病风险增加有关。
Sci Rep. 2023 Jul 28;13(1):12230. doi: 10.1038/s41598-023-39154-x.
8
Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.瘦型非酒精性脂肪性肝病与中国西北地区健康人群 2 型糖尿病发病风险的关联：一项 2 年随访期的回顾性队列研究。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1173757. doi: 10.3389/fendo.2023.1173757. eCollection 2023.
9
Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease.血清miR-4488作为瘦型非酒精性脂肪性肝病的潜在生物标志物。
Ann Transl Med. 2023 Feb 28;11(4):173. doi: 10.21037/atm-22-6620. Epub 2023 Feb 21.
10
Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.脂联素-瘦素比值可早期发现非肥胖型非酒精性脂肪性肝病，与胰岛素抵抗无关。
Ann Med. 2023 Dec;55(1):634-642. doi: 10.1080/07853890.2023.2179106.